NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









DeepSight Technology

DeepSight Technology

Private
Santa Clara, CaliforniaHealthcare & Life Scienceshttps://www.deepsight.com/

Last Round

Series C

Aug 19, 2025

Total Funding Raised

$85M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

DeepSight Technology is a health technology company that develops proprietary sensing technology and ultrasound platforms to enhance medical imaging and improve precision in interventional procedures.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical Imaging, Sensors

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

ultrasound imagingneedle guidancemedical deviceinterventional ultrasoundpoint-of-care ultrasoundPOCUSmedical imagingultrasound hardwareclinical imagingmedical AIOEM integrationsensor technologyimage enhancement

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

DeepSight Technology Comparables

Compare DeepSight Technology with similar companies based on industry and business-model similarity.

DeepSight Technology comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
EchoNous
83%
Rivanna Medical
81%
eZono AG
78%

DeepSight Technology Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CAug 19, 2025
Series AOct 11, 2021

Key People

Founding team and executive leadership

John Chong

Chief Operating Officer And Head Of Engineering

Executive Team

DeepSight Technology Investors

Notable investors and investment history

DeepSight Technology investors
InvestorRounds
Deerfield ManagementSeries A
Time BioVenturesSeries A
RONA HoldingsSeries C, Series A
EDBISeries C
Wing Venture CapitalSeed
Wing Venture CapitalSeries A
Alter Venture PartnersSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 10, 2026

    NeedleVue Mini ultrasound device to debut at SIR conference.

  • Apr 10, 2026

    Launched the NeedleVue Mini ultrasound guidance device.

DeepSight Technology Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

DeepSight Technology Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about DeepSight Technology's valuation, stock price, and market status.

Firmographic Details

HeadquartersSanta Clara, California
Employee Range72
Year Founded2019
Last FundingAug 19, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.